Trial Profile
Phase 3 confirmatory study of K-115 added to timolol in patients with primary open-angle glaucoma (POAG) and ocular hypertension (OH)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa
- 03 Jun 2016 New trial record